What is biomedicine? A socio-historical outline;Qu'est-ce que la bomédecine? Repères soco-historiques

Medecine/Sciences

Volumn 19, Issue 12, 2003, Pages 1280-1287

  Cambrosio, Alberto ^a   Keating, Peter ^b  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; CELL SURFACE MARKER; DNA;

AUTOMATION; BIOMEDICINE; CLINICAL MEDICINE; HEMATOLOGY; HISTORY OF MEDICINE; LABORATORY; MEDICAL PRACTICE; ONCOLOGY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; SOCIAL ASPECT;

EID: 0348108111     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/200319121280     Document Type: Review

References (35)

1. Tubiana M. Histoire de la pensée médicale. Les chemins d'Esculape. Paris: Flammarion, 1995: 713 p.
2. Gaudillière JP. Inverter la biomédecine. La France, l'Amérique et la production des savoirs du vivant (1945-1965). Paris: La Découverte, 2002: 392 p.
3. Ahrens EH. The crisis in clinical research: Overcoming institutional obstacles. New York: Oxford University Press, 1992, 236 p.
4. Picard JF. De la médecine expérimentale (1865) à l'INSERM (1964). In: Debru C, Gayon J, Picard JF, ed. Les sciences biologigues et médicales en France, 1920-1950, Paris: CNRS, 1994: 329-44.
5. Dill KA. Strengthening biomedicine's roots. Nature 1999; 400: 309-10.
6. Schechter AN. Medicine and biology are more than biomedicine. Nature 1999; 401: 424.
7. Schechter AN. The crisis in clinical research: Endangering the half-century National institutes of health consensus. JAMA 1998; 280: 1440-2.
8. Löwy I. Between bench and bedside. Science, healing, and interleukin-2 in a cancer ward. Cambridge, Mass.: Harvard University Press, 1996: 370 p.
9. Sinding C. Le clinicien et le chercheur. Des grandes maladies de carence à la médecine moléculaire, 1880-1980. Paris: Presses Universitaires de France, 1991: 284 p.
10. Feinstein AR. The crisis in clinical research. Bull Hist Med 1995; 69: 288-91.
11. Chabner BA, Boral AL, Multani P. Translational research: Walking the bridge between idea and cure. Seventeenth Bruce F. Cain memorial award lecture. Cancer Res 1998; 58: 4211-6.
12. Thomson AL. Half a century of medical research. London: HMSO, 1973-1975.
13. Rothstein WG. American medical schools and the practice of medicine: A history. New York: Oxford University Press, 1987: 408 p.
14. Geiger RL. Science and the University. In: Krige J, Pestre D, ed. Science in the twentieth century. Amsterdam: Harwood Academic, 1997: 159-74.
15. Boot CC. Clinical Research. In: Bynum WF, Porter R, ed. Companion encyclopedia of the history of medicine. Vol. 1. London: Routledge, 1993: 205-29.
16. Lawrence C. Clinical Research. In: Krigel, Pestre D, ed. Science in the twentieth century. Amsterdam: Harwood Academic, 1997: 439-59.
17. Keating P, Cambrosio A. Biomedical platforms. Realigning the normal and the pathological in late-twentieth-century medicine. Cambridge, MA: MIT Press, 2003: 560 p.
18. Downey H. Handbook of hematology. Vol. 3. New York: Hafner, 1965.
19. Van Danger JJM, Adriaarser HJ. Immunobiology of leukemia. In: Henderson ES, Lister TA, Greaves MF, ed. Leukemia. 6th ed. Philadelphia: Saunders, 1996: 83-130.
20. Canguilhem G. Le normal et le pathologique. Paris: Presses Universitaires de France, 1972, 226 p.
21. Whittaker MH, Willman CL. A practical guide to the use of molecular genetic techniques in the diagnosis of lymphoid malignancies. In: Fenoglio-Preiser CM, Willman CL, ed. Molecular diagnostics in pathology. Baltimore: Williams and Wilkins, 1991: 123-48.
22. Keating P, Cambrosio A. Real compared to what? diagnosing leukemias and lymphomas. In: Lock M, Young A, Cambrosio A, ed. Living and working with the new medical technologies. Intersections of inquiry. Cambridge, UK: Cambridge University Press, 2000: 103-34.
23. Rheinberger HJ. Toward a history of epistemic things. Synthesizing proteins in the test tube. Stanford: Stanford University Press, 1997: 325 p.
24. Moulin AM. Le dernier langage de la médecine. Histoire de l'immunologie de Pasteur au sida. Paris: Presses Universitaires de France, 1991; 447 p.
25. Raff MC. Cell-surface immunology. Sci Am 1976; 234: 30-9.
26. Austoker J. A history of the Imperial cancer research fund, 1902-1986. Oxford: Oxford University Press, 1988: 375 p.
27. Keating P, Cambrosio A. The new genetics and cancer. The contributions of clinical medicine in the era of biomedicine. J His Med Allied Sci 2001; 56: 321-52.
28. Morange M. Histoire de la biologie moléculaire. Paris: La Découverte, 1994: 358 p.
29. Keating P, Cambrosio A. Signs, markers, profiles, and signatures: Clinical hematology meets the new genetics (1980-2000). New Genetics and Society 2004; 23 (sous presse).
30. Thomas L. Aspects of biomedical science policy. Washington: National academy of sciences - Institute of medicine, 1972: 16 p.
31. Lenoir T, Hays M. The Manhattan project for biomedicine. In: Sloan PR, ed. Controlling our destinies. Historical, philosophical, ethical, and theological perspectives on the Human genome project. South Bend, Indiana: University of Notre Dame Press, 2000: 29-62.
32. Reiser SJ. Medicine and the reign of technology. Cambridge, UK: Cambridge University Press, 1981: 317 p.
33. Keating P, Limoges C, Cambrosio A. The automated laboratory. The generation and replication of work in molecular genetics. In: Fortun M, Mendelsohn E, ed. The Practices of human genetics. Dordrecht: Kluwer, 1999: 125-42.
34. Kaufert PA. Screening the Body: The pap smear and the mammogram. In: Lock M, Young A, Cambrosio A, ed. Living and working with the new medical technologies. Intersections of inquiry. Cambridge, UK: Cambridge University Press, 2000: 165-83.
35. Bernard J. Summing up. Blood Cells 1980; 6: 499-500.